Eye Care in France
Euromonitor International's Eye Care in France market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 48 | Publication date: Dec 2007
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Allergy eye care; Antibiotic eye care; Standard eye care
Table of contents
OTC HEALTHCARE IN FRANCE : MARKET INSIGHT
EXECUTIVE SUMMARY
Slow Growth
De-reimbursement Limited Impact
Pharmacies Stronghold Lessening
Changing Mentalities
Potential Growth
KEY TRENDS AND DEVELOPMENTS
OTC Products in Difficult Trading Conditions
Demographic Trends Impact Demand
De-reimbursement: Does it Work?
Economic Growth Increases Visits to Private Doctors
Hectic Lifestyles and Rising Health Awareness Drive Sales
MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Penetration of Private Label by Sector 2002-2006
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification
Advertising
Packaging and Labelling
Distribution
De-listing or De-reimbursement
Vitamins and Dietary Supplements Registration and Classification
Generics
Consumer Expenditure on Health Goods and Medical Services
Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources
LOCAL COMPANY PROFILES - FRANCE
ARKOPHARMA SA, LABORATOIRES PHARMACEUTIQUES - OTC HEALTHCARE - FRANCE
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Arkopharma SA, Laboratoires Pharmaceutiques: Key Facts
Summary 3 Arkopharma SA, Laboratoires Pharmaceutiques: Operational Indicators 2004-2006
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Arkopharma SA, Laboratoires Pharmaceutiques: Competitive Position 2006
BEAUFOUR-IPSEN SA - OTC HEALTHCARE - FRANCE
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Beaufour-Ipsen SA: Key Facts
Summary 6 Beaufour-Ipsen SA: Operational Indicators 2004-2006
COMPANY BACKGROUND
PRODUCTION
Summary 7 Beaufour-Ipsen SA: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 8 Beaufour-Ipsen SA: Competitive Position 2006
JUVA SANTé, LABORATOIRES - OTC HEALTHCARE - FRANCE
STRATEGIC DIRECTION
KEY FACTS
Summary 9 Juva Santé, Laboratoires: Key Facts
Summary 10 Juva Santé, Laboratoires: Operational Indicators 2004-2006
COMPANY BACKGROUND
PRODUCTION
Summary 11 Juva Santé, Laboratoires: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 12 Juva Santé, Laboratoires: Competitive Position 2006
LABORATOIRES MARTIN-JOHNSON & JOHNSON-MSD SAS - OTC HEALTHCARE - FRANCE
STRATEGIC DIRECTION
KEY FACTS
Summary 13 Laboratoires Martin-Johnson & Johnson-MSD SAS: Key Facts
Summary 14 Laboratoires Martin-Johnson & Johnson-MSD SAS: Operational Indicators 2004-2006
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 15 Laboratoires Martin-Johnson & Johnson-MSD SAS: Competitive Position 2006
PFIZER SANTé GRAND PUBLIC - OTC HEALTHCARE - FRANCE
STRATEGIC DIRECTION
KEY FACTS
Summary 16 Pfizer Santé Grand Public: Key Facts
Summary 17 Pfizer Santé Grand Public: Operational Indicators 2004-2006
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 18 Pfizer Santé Grand Public: Competitive Position 2006
PIERRE FABRE SA, LABORATOIRES - OTC HEALTHCARE - FRANCE
STRATEGIC DIRECTION
KEY FACTS
Summary 19 Pierre Fabre SA, Laboratoires: Key Facts
Summary 20 Pierre Fabre SA, Laboratoires: Operational Indicators 2004-2006
COMPANY BACKGROUND
PRODUCTION
Summary 21 Pierre Fabre SA, Laboratoires: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 22 Pierre Fabre SA, Laboratoires: Competitive Position 2006
THéRAPLIX SA - OTC HEALTHCARE - FRANCE
STRATEGIC DIRECTION
KEY FACTS
Summary 23 Théraplix SA: Key Facts
Summary 24 Théraplix SA: Operational Indicators 2004-2006
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 25 Théraplix SA: Competitive Position 2006
UPSA, LABORATOIRES - OTC HEALTHCARE - FRANCE
STRATEGIC DIRECTION
KEY FACTS
Summary 26 UPSA Conseil SAS: Key Facts
Summary 27 UPSA Conseil SAS: Operational Indicators 2004-2006
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 28 UPSA, Laboratoires: Competitive Position 2006
URGO, LABORATOIRES - OTC HEALTHCARE - FRANCE
STRATEGIC DIRECTION
KEY FACTS
Summary 29 Urgo, Laboratoires: Key Facts
Summary 30 Urgo, Laboratoires: Operational Indicators 2004-2006
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 31 Urgo, Laboratoires: Competitive Position 2006
EYE CARE IN FRANCE
OVERVIEW
SECTOR DATA
Table 12 Sales of Eye Care by Subsector: Value 2001-2006
Table 13 Sales of Eye Care by Subsector: % Value Growth 2001-2006
Table 14 Eye Care Company Shares by Retail Value 2002-2006
Table 15 Eye Care Brand Shares by Retail Value 2003-2006
Table 16 Forecast Sales of Eye Care by Subsector: Value 2006-2011
Table 17 Forecast Sales of Eye Care by Subsector: % Value Growth 2006-2011